Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Cystic Fibrosis Trials: CDER Officials Disagree Over Value Of FEV₁ Endpoint

Oct 11 2010

• By Martin Berman-Gorvine

Related Content

Cystic Fibrosis Trial Endpoints May Be Revised Following FDA Workshop

Aug 02 2010

Gilead Prices Cystic Fibrosis Drug Cayston At Slight Premium To Competitor

Mar 01 2010

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window